Becton Dickinson (XSWX:BDX) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Becton Dickinson Forward PE Ratio Related Terms
Becton Dickinson Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson Forward PE Ratio Chart
Becton Dickinson Annual Data
Trend
2016-09
2017-09
2018-09
2019-09
2020-09
2021-09
2022-09
Forward PE Ratio
18.12
18.87
20.83
18.69
20.24
20.28
19.65
Becton Dickinson Quarterly Data
2016-06
2016-09
2017-03
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2026-03
Forward PE Ratio
17.54
18.12
17.76
18.38
18.87
21.37
20.20
16.34
20.83
17.99
20.16
18.83
18.69
19.76
20.53
19.76
20.24
21.88
20.70
20.41
20.28
20.88
20.28
17.99
19.65
21.65
21.41
13.03
XSWX:BDX vs MDLN, RMD, WST: Forward PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Becton Dickinson (XSWX:BDX) has a Forward PE Ratio of 11.37 as of Jul. 13, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Becton Dickinson and its competitors. According to the industry distribution chart, Becton Dickinson ranks #77 out of 392 companies in the Medical Devices & Instruments industry, placing it in the top 19.6%.
Is Becton Dickinson's Forward PE Ratio too high?
Becton Dickinson's current Forward PE Ratio is 11.37. The Medical Devices & Instruments industry median Forward PE Ratio is 19.14. Becton Dickinson's value of 11.37 is 40.6% below this industry median. Based on the distribution chart, Becton Dickinson ranks #77 out of 392 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Becton Dickinson has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Forward PE Ratio compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #77 out of 392 companies for Forward PE Ratio. This places Becton Dickinson in the top 20% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 19.14. Becton Dickinson's value of 11.37 is 40.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.14, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current Forward PE Ratio of 11.37 is 40.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current Forward PE Ratio is 11.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Forward PE Ratio of 11.37. The stock's GF Value™ is CHF152.77, compared to a current price of CHF122.44 — trading 19.9% below its estimated fair value. The current Forward PE Ratio is 11.37 and 40.6% below the Medical Devices & Instruments industry median of 19.14. Becton Dickinson's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Forward PE Ratio is 11.37 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of CHF122.44 is trading 19.9% below its estimated GF Value™ of CHF152.77.
Key valuation signals for XSWX:BDX:
Forward PE Ratio: 11.37
GF Value™: CHF152.77 vs. price of CHF122.44 (19.9% below fair value)
Industry Position: 40.6% below the Medical Devices & Instruments median (#77 of 392)
No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score
Get the complete analysis for XSWX:BDX
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BDX has been successfully added to your 